Fmoc-Arg(Pbf)-OH, Fmoc-Ala-OH and HATU were purchased from GL Biochem (Shanghai) Ltd. NMM was purchase from Fluka, anhydrous DMF were purchased from Aldrich and Auspep, and were used as recieved. DCM and Et 3 N were freshly distilled over CaH 2 prior to use. 20% piperidine in anhydrous DMF was freshly prepared prior to use. All other commercially available chemicals were used as received. NMR measurements were carried out either on Bruker Avance DPX 300 (300 MHz) or DRX400 (400 MHz) spectrometers and the peaks assigned using COSY, HMQC, HMBC NMR program. The 1 H and 13 C spectra were run in deuterochloroform (CDCl 3 ) with δ 7.26 and 77.36 ppm (residual CHCl 3 ) used as an internal reference. MS (low-resolution electron spray ionization, ESI) measurements were run in methanol on a Micromass Platform Electrospray mass spectrometer. HRMS (high-resolution mass spectrometry) measurements were run in methanol on a Bruker BioApex 4.7 Teltra FT-ICR instrument fitted with an Analytica Electrospray Source at high resolution and calibrated using NaI clusters, or on an Agilent G1969A LC-TOF system with reference mass correction Agilent 1100 Series LC. M.p. (melting points) were determined using a Buchi Melting Point B-545 melting point apparatus. 1-((3-((4R,7S,7aR,12bS) Fmoc-Arg(Pbf)-OH 10 (84 mg, 0.13 mmol) and HATU (246 mg, 0.65 mmol) were partially dissolved in dry DCM (1 mL) and anhydrous DMF (3 mL). NMM (85 L, 0.77 mmol) was added and the yellow solution was quickly added to a stirring solution of 3-((4R,7S,7aR,12bS)-7,9-bis((tert-butyldimethylsilyl)oxy)-4,4a,7,7a-tetrahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-3(2H)-yl)propan-1-amine 8 (72 mg, 0.13 mmol) in dry DCM (1 mL) and anhydrous DMF (0.5 mL) and stirred at room temperature under N 2 overnight. Solvent was removed and the resulting mixture was treated with sat. aq. NaHCO 3 solution (10 mL) and extracted with DCM (3×10 mL). The organic layers were combined, washed with sat. aq. NaCl solution, dried over anhydrous MgSO 4 , filtered and concentrated to give an orange oil which was chromatograped (Al 2 O 3 neutral) using Hexane:EtOAc (1:4), EtOAc:Hexane:MeOH (4:4:1) and EtOAc:DCM:MeOH (4:4:3) to afford the titled product 1 as a white powder (m.p. = 92-93 ˚C, 65 mg, 31%, R f = 0.7 in EtOAc:Hexane:MeOH (4:4:1)) and guanidine 3 as a light yellow solid (m.p. = 100-101.5˚C, 42 mg, 36% yield, R f = 0.6 in EtOAc:Hexane:MeOH (4:4:1)).
Compound 1:
1 H NMR (400MHz, CDCl 3 ): δ 0. 07, 0.10, 0.13, 0.19 (4×s, 12H, 4×Si(CH 3 ) 3 ); 0.91, 0.97 (2s, 18H, 2×SiC(CH 3 ) 3 ); 1.41 (s, 6H, C(CH 3 ) 2 -Pbf); 1.56-2.10 (m, 7H, H15, H2', H3'', H4''); 1.98-2.09 (m, 1H, H15); 2.05 (s, 3H, ArCH 3 -Pbf); 2.41-2.63 (m, 2H, H10, H16); 2.48 (s, 3H, ArCH 3 -Pbf); 2.57 (s, 3H, ArCH 3 -Pbf); 2.71 (m, 1H, H14); 2.68-2.98 (m, 4H, H3', H10, H16); 2.88 (s, 2H, CH 2 -Pbf); 3.20-3.39 (m, 4H, H1', H5''); 3.68 (m, 1H, H9); 4.08-4.34 (m, 6H, H6, H3', H2'', OCH 2 CH-Fmoc and OCH 2 CH-Fmoc); 4.63 (d, J = 0.9 Hz, 1H, H5); 5.12 (dm, J = 9.5 Hz, 1H, H8); 5.57 (dm, J = 9.8 Hz, 1H, H7); 6.10 (bm, 1H, NH); 6.27 (bs, 2H, NH); 6.36 (d, J = 8.2 Hz, 1H, H1); 6.54 (d, J = 8.1 Hz, 1H, H2); 7.23 (td, J = 7.4, 0.7 Hz, 2H, ArCH-Fmoc); 7.33 (t, J = 7.4 Hz, 2H, ArCH-Fmoc); 7.53-7.56 (m, 2H, ArCH-Fmoc); 7.69 (d, J = 7.4 Hz, 2H, ArCH-Fmoc). 13 C NMR (75MHz, CDCl 3 ): δ -4. 69, Synthesis of (2S)-2-amino-N-(3-((4R,7S,7aR,12bS)-7,9-bis((tert-butyldimethylsilyl)oxy)-4,4a,7,7a-tetrahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-3(2H)-yl)propyl)-5-(3-((2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-yl)sulfonyl)guanidino)pentanamide (2) Method: a To a freshly prepared 20% piperidine in anhydrous DMF (12 mL), was added 1 (520 mg, 0.44 mmol). The resulting mixture was stirred at room temperature for 2 hours, and then was concentrated under reduced pressure to give a yellow oil which was chromatographed (neutral Al 2 O 3 ), using Hexane:EtOAc (1:4), EtOAc:Hexane:MeOH (4:4:1) and DCM:MeOH:NH 4 OH (9:4:0.4) to afford a mixture of the titled product 2 and the guanidine bi-product 3 as a pale yellow solid (m.p. = 123.1-123.9 ˚C. 360 mg 
Synthesis of (S)-(9H-fluoren-9-yl)methyl (1-((3-morpholinopropyl)amino)-1-oxo-5-(3-
((2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-yl)sulfonyl)guanidino)pentan-2-yl)carbamate 4 and 1,1,3,3-tetramethyl-2-(3-morpholinopropyl)guanidine (5) NMM (245 L, 2.22 mmol) was added to a solution of Fmoc-Arg(Pbf)-OH (240 mg, 0.37 mmol) and HATU (700 mg, 1.84 mmol) in mixed dry DCM and anhydrous DMF (4:12 mL) and the resulting mixture was stirred at room temperature for two minutes. This mixture, was then added to a solution of 3-morpholinopropan-1-amine 9 (54 µL, 0.37 mmol) in mixed dry DCM and anhydrous DMF (5:3 mL) and stirred under N 2 at room temperature for 3 days. The solvent was removed and the resulting mixture treated with sat. aq. NaHCO 3 solution (30 mL) and then was extracted with DCM (3 x 20 mL). The combined organic layer was dried over anhydrous MgSO 4 , filtered, and solvent removed in vacuo to give a yellow oil which was chromatographed (neutral Al 2 O 3 ), using Hexane:EtOAc (1:4), EtOAc, DCM, and then 2%
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MeOH in DCM to afford the titled product 4 as a yellow foam (m.p. = 83.7-84.3 ˚C. 166 mg, 58% yield, R f = 0.28 (2% MeOH in DCM)) and guanidine 5 as a colouless oil (23 mg, 25% yield, R f = 0.37 (2% MeOH in DCM)). 
Synthesis of (S)-2-amino-N-(3-morpholinopropyl)-5-(3-((2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-yl)sulfonyl)guanidino)pentanamide (6)
A solution of 4 (100 mg, 0.13 mmol) in triethylamine solution (180 µL, 1.29 mmol in 2 mL anhydrous DMF) was stirred at room temperature under N 2 overnight. The reaction mixture was concentrated in vacuo to give a brown oil which was chromatographed (Al 2 O 3 neutral) using Hexane, EtOAc and DCM:MeOH:NH 4 OH (9:1:0.1), as eluents to afforded the title compound 6 as a light yellow oil (61 mg, 72% yield, R f = 0.6 (DCM:MeOH:NH 4 OH, 9:1:0.1). 3-((4R,7S,7aR,12bS )-7,9-bis((tertbutyldimethylsilyl)oxy)-4,4a,7,7a-tetrahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-3(2H)-yl)propyl)amino)-1-oxopropan-2-yl)carbamate (7)
Synthesis of (9H-fluoren-9-yl)methyl ((2S)-1-((
NMM (135 L, 1.23 mmol) was added to a solution of Fmoc-Ala-OH (64 mg, 0.205 mmol) and HATU (390 mg, 1.02 mmol) in a mixed dry DCM and anhydrous DMF (1:3 mL) and the resulting mixture was stirred at room temperature for two minutes. This mixture was added to the solution of 8 (114 mg, 0.205 mmol) in a mixed dry DCM and anhydrous DMF (2:1 mL) and stirred under N 2 at room temperature for 3 days. The solvent (DCM and approximately half of the DMF) was removed and sat. aq. NaHCO 3 solution (20 mL) was added. The resulting mixture was extracted with DCM (3 x 15 mL), the combined organic layer dried over anhydrous MgSO 4 , filtered and solvent was removed in vacuo to give an organge oilwhich was chromatographed (Al 2 O 3 neutral), using Hexane:EtOAc (1:4), EtOAc:Hexane:MeOH (4:4:1), DCM:MeOH (9:0.5) and DCM:MeOH:NH 4 OH (9:4:0.4) to afford the titled product 7 as a colourlerss oil (100 mg, 57% yield, R f = 0.5 in EtOAc:Hexane (1:1)) and guanidine 3 as a light yellow solid (36 mg, 27% yield, R f = 0.4 in DCM:MeOH (9:0.5)). 
Synthesis of (2S)-2-amino-N-(3-((4R,7S,7aR,12bS)-7,9-bis((tert-butyldimethylsilyl)oxy)-4,4a,7,7a-tetrahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-3(2H)-yl)propyl)propanamide (11)
To a freshly prepared 20% piperidine in anhydrous DMF (2 mL), was added 7 (67 mg, 0.079 mmol). The resulting mixture was stirred at room temperature for 2 hours, and then was concentrated under reduced pressure to give a yellow oil which was chromatographed (Al 2 O 3 neutral), using Hexane:EtOAc (1:4), EtOAc:Hexane:MeOH (4:4:1) and DCM:MeOH:NH 4 OH (9:4:0.4) to afford the titled product 11 as a colourless oil (29 mg, 59% yield, R f = 0.1 in DCM:MeOH:NH 4 OH (9:4:0.4)). 
